192 related articles for article (PubMed ID: 20008439)
1. Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI rats.
Starlard-Davenport A; Tryndyak VP; James SR; Karpf AR; Latendresse JR; Beland FA; Pogribny IP
Carcinogenesis; 2010 Mar; 31(3):376-81. PubMed ID: 20008439
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression.
Kovalchuk O; Tryndyak VP; Montgomery B; Boyko A; Kutanzi K; Zemp F; Warbritton AR; Latendresse JR; Kovalchuk I; Beland FA; Pogribny IP
Cell Cycle; 2007 Aug; 6(16):2010-8. PubMed ID: 17700064
[TBL] [Abstract][Full Text] [Related]
3. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
4. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter.
Strunnikova M; Schagdarsurengin U; Kehlen A; Garbe JC; Stampfer MR; Dammann R
Mol Cell Biol; 2005 May; 25(10):3923-33. PubMed ID: 15870267
[TBL] [Abstract][Full Text] [Related]
5. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
6. The Role of Dietary Extra Virgin Olive Oil and Corn Oil on the Alteration of Epigenetic Patterns in the Rat DMBA-Induced Breast Cancer Model.
Rodríguez-Miguel C; Moral R; Escrich R; Vela E; Solanas M; Escrich E
PLoS One; 2015; 10(9):e0138980. PubMed ID: 26401660
[TBL] [Abstract][Full Text] [Related]
7. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
9. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
10. [DNA methylation and histone modification relate to RASSF1A gene deletion in laryngeal carcinoma tissues].
Yang J; Ji WY; Qu YR; He LX; Zhao XD; Jin MZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):308-12. PubMed ID: 21624251
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
12. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats.
Pogribny IP; Ross SA; Tryndyak VP; Pogribna M; Poirier LA; Karpinets TV
Carcinogenesis; 2006 Jun; 27(6):1180-6. PubMed ID: 16497704
[TBL] [Abstract][Full Text] [Related]
13. Oncogenes, estradiol biotransformation, and mammary carcinogenesis.
Telang NT
Ann N Y Acad Sci; 1996 Apr; 784():277-87. PubMed ID: 8651576
[No Abstract] [Full Text] [Related]
14. Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis.
Dammann R; Schagdarsurengin U; Strunnikova M; Rastetter M; Seidel C; Liu L; Tommasi S; Pfeifer GP
Histol Histopathol; 2003 Apr; 18(2):665-77. PubMed ID: 12647816
[TBL] [Abstract][Full Text] [Related]
15. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic alterations in RASSF1A in human aberrant crypt foci.
Greenspan EJ; Jablonski MA; Rajan TV; Levine J; Belinsky GS; Rosenberg DW
Carcinogenesis; 2006 Jul; 27(7):1316-22. PubMed ID: 16513682
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.
Di Gioia S; Bianchi P; Destro A; Grizzi F; Malesci A; Laghi L; Levrero M; Morabito A; Roncalli M
BMC Cancer; 2006 Apr; 6():89. PubMed ID: 16606445
[TBL] [Abstract][Full Text] [Related]
18. Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.
Mense SM; Singh B; Remotti F; Liu X; Bhat HK
Carcinogenesis; 2009 Jul; 30(7):1202-8. PubMed ID: 19406931
[TBL] [Abstract][Full Text] [Related]
19. Reversibility of pre-malignant estrogen-induced epigenetic changes.
Kutanzi KR; Koturbash I; Kovalchuk O
Cell Cycle; 2010 Aug; 9(15):3078-84. PubMed ID: 20699652
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer.
Kawamoto K; Okino ST; Place RF; Urakami S; Hirata H; Kikuno N; Kawakami T; Tanaka Y; Pookot D; Chen Z; Majid S; Enokida H; Nakagawa M; Dahiya R
Clin Cancer Res; 2007 May; 13(9):2541-8. PubMed ID: 17473182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
